Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: Updated clinical practice guidelines

被引:32
作者
Segal, N
Leibovitz, E
Dagan, R
Leiberman, A [1 ]
机构
[1] Soroka Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84101 Beer Sheva, Israel
关键词
acute otitis media; treatment guidelines; diagnosis; antibiotics;
D O I
10.1016/j.ijporl.2005.05.003
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The treatment of children with AOM has to rely on an accurate diagnosis and a clear discrimination between AOM and serous otitis media. The last decade has seen major changes in the epidemiology of AOM with an earlier onset of disease and a greater proportion of children with recurrent/complicated AOM. The processes of changing susceptibility of bacterial. pathogens added a major problem in treatment selection. Tastier, more efficient, safe and conveniently-dosing as well as cost effective drugs are required to achieve adherence to therapy. The recent published guidelines for the treatment of AOM in the present era of pneumoccocal resistance represent a major step forward in the approach to the management of this disease by establishing a clear hierarchy among the various therapeutic agents. A 48-72 h observation option without use of antibacterial. therapy in selected children with uncomplicated AOM should be promoted. Immunization against S. pneumoniae with the heptavalent pneumococcal conjugated vaccines was showed to result in a decrease in the frequency of AOM caused by this pathogen, including AOM caused by antibiotic-resistant S. pneumoniae. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1311 / 1319
页数:9
相关论文
共 62 条
  • [1] Adair-Bischoff CE, 1998, ARCH PEDIAT ADOL MED, V152, P127
  • [2] APPELMAN CL, 1999, HUISARTS WET, V42, P362
  • [3] ASHER E, 2004, 43 INT C ANT AG CHEM
  • [4] Efficacy of twice-daily dosing of amoxycillin/clavulanate in acute otitis media in children
    Behre, U
    Burow, HM
    Quinn, P
    Cree, F
    Harrison, HE
    [J]. INFECTION, 1997, 25 (03) : 163 - 166
  • [5] Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
    Black, S
    Shinefield, H
    Fireman, B
    Lewis, E
    Ray, P
    Hansen, JR
    Elvin, L
    Ensor, KM
    Hackell, J
    Siber, G
    Malinoski, F
    Madore, D
    Chang, I
    Kohberger, R
    Watson, W
    Austrian, R
    Edwards, K
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) : 187 - 195
  • [6] Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media
    Block, SL
    Hedrick, J
    Harrison, CJ
    Tyler, R
    Smith, A
    Findlay, R
    Keegan, E
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (09) : 829 - 833
  • [7] Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy
    Block, SL
    Hedrick, JA
    Kratzer, J
    Nemeth, MA
    Tack, KJ
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (12) : S153 - S158
  • [8] 10-YEAR REVIEW OF OTITIS-MEDIA PATHOGENS
    BLUESTONE, CD
    STEPHENSON, JS
    MARTIN, LM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (08) : S7 - S11
  • [9] Implications of pharmacokinetics in making choices for the management of acute otitis media
    Blumer, JL
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (06) : 565 - 570
  • [10] Changes in frequency and pathogens causing acute otitis media in 1995-2003
    Casey, JR
    Pichichero, ME
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (09) : 824 - 828